Shaun McColl graduated with a Ph.D. from the University of Adelaide 1987.  He was a Post-Doctoral Fellow at Université Laval in Québec City in Canada from 1987-1989 an Assistant Professor of Medicine at Université Laval from 1989-1993. During that period of time he developed a research interest in the molecular control of cell movement.  He returned to Australia as a Research Fellow at the John Curtin School of Medical Research at the Australian National University from 1993-1995 and took up a faculty appointment at the University of Adelaide in 1995.  He has held a Personal Chair in Immunology since 2003.  He was awarded a D.Sc. by the University of Adelaide and was made a Fellow of the Faculty of Science of the RCPA in 2013.  More recently he was appointed Vice-President of Chemokine Platform Technology at Carina Biotech, a CAR-T cell-based start-up company. 

Professor McColl’s laboratory investigates the molecular control of cell migration and its pathophysiology, with the major focus being on identifying mechanisms by which chemokines and their receptors regulate the immune response either during infection or in the context of diseases such as multiple sclerosis and metastatic cancer. This has provided a number of insights into the function and regulation of the chemokine gene superfamily in a range of immune and therapeutic contexts.